Kimberly-Clark (KMB) 10-Q 23 Jul 19 2019 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2019	Jul. 16, 2019
Entity Information [Line Items]
Entity Central Index Key	0000055785
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Common Stock, Shares Outstanding		344,136,273
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2019
Document Transition Report	false
Entity File Number	1-225
Entity Registrant Name	KIMBERLY CLARK CORPORATON
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	39-0394230
Entity Address, Address Line One	P.O. Box 619100
Entity Address, City or Town	Dallas,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75261-9100
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Filer Category	Large Accelerated Filer
City Area Code	972
Local Phone Number	281-1200
Entity Small Business	false
Entity Emerging Growth Company	false
Common Stock | NEW YORK STOCK EXCHANGE, INC.
Entity Information [Line Items]
Security Exchange Name	NYSE
Title of 12(b) Security	Common Stock
Trading Symbol	KMB
0.625% Notes Due 2024 [Member] | NEW YORK STOCK EXCHANGE, INC.
Entity Information [Line Items]
Security Exchange Name	NYSE
Title of 12(b) Security	0.625% Notes due 2024
Trading Symbol	KMB24

Consolidated Income Statement

Consolidated Income Statement - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Net Sales	$ 4,594	$ 4,604	$ 9,227	$ 9,335
Cost of products sold	3,108	3,149	6,313	6,556
Gross Profit	1,486	1,455	2,914	2,779
Marketing, research and general expenses	811	771	1,580	1,850
Other (income) and expense, net	5	10	9	8
Operating Profit	670	674	1,325	921
Nonoperating expense	(11)	(36)	(22)	(45)
Interest income	2	3	5	5
Interest expense	(67)	(68)	(132)	(134)
Income Before Income Taxes and Equity Interests	594	573	1,176	747
Provision for income taxes	(132)	(138)	(275)	(242)
Income Before Equity Interests	462	435	901	505
Share of net income of equity companies	33	30	60	57
Net Income	495	465	961	562
Net income attributable to noncontrolling interests	(10)	(10)	(22)	(14)
Net Income Attributable to Kimberly-Clark Corporation	$ 485	$ 455	$ 939	$ 548
Per Share Basis
Basic	$ 1.41	$ 1.30	$ 2.73	$ 1.57
Diluted	$ 1.40	$ 1.30	$ 2.71	$ 1.56

Consolidated Statement Of Compr

Consolidated Statement Of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement of Comprehensive Income [Abstract]
Net Income	$ 495	$ 465	$ 961	$ 562
Other Comprehensive Income (Loss), Net of Tax
Unrealized currency translation adjustments	(4)	(381)	22	(264)
Employee postretirement benefits	26	79	22	79
Other	(3)	29	(20)	28
Total Other Comprehensive Income (Loss), Net of Tax	19	(273)	24	(157)
Comprehensive Income	514	192	985	405
Comprehensive income attributable to noncontrolling interests	(9)	1	(16)	(4)
Comprehensive Income Attributable to Kimberly-Clark Corporation	$ 505	$ 193	$ 969	$ 401

Consolidated Balance Sheet

Consolidated Balance Sheet - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 534	$ 539
Accounts receivable, net	2,397	2,164
Inventories	1,856	1,813
Other current assets	534	525
Total Current Assets	5,321	5,041
Property, Plant and Equipment, Net	7,207	7,159
Investments in Equity Companies	249	224
Goodwill	1,478	1,474
Other Assets	1,092	620
TOTAL ASSETS	15,347	14,518
Current Liabilities
Debt payable within one year	1,291	1,208
Trade accounts payable	2,993	3,190
Accrued expenses and other current liabilities	1,946	1,793
Dividends payable	355	345
Total Current Liabilities	6,585	6,536
Long-Term Debt	6,701	6,247
Noncurrent Employee Benefits	889	931
Deferred Income Taxes	513	458
Other Liabilities	571	328
Redeemable Preferred Securities of Subsidiaries	38	64
Stockholders' Equity
Kimberly-Clark Corporation	(178)	(287)
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	473	473
Additional Paid in Capital	510	548
Treasury Stock, Value	(4,062)	(3,956)
Retained Earnings (Accumulated Deficit)	6,170	5,947
Accumulated Other Comprehensive Income (Loss), Net of Tax	(3,269)	(3,299)
Noncontrolling Interests	228	241
Total Stockholders' Equity	50	(46)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 15,347	$ 14,518

Consolidated Balance Sheet Pare

Consolidated Balance Sheet Parenthetical - $ / shares $ / shares in Thousands, shares in Millions	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred Stock, Par or Stated Value Per Share	$ 0	$ 0
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0
Common Stock, Par or Stated Value Per Share	$ 1,250	$ 1,250
Common Stock, Shares Authorized	1,200,000,000	1,200,000,000
Common Stock, Shares, Issued	378,597,000	378,597,000
Treasury Stock, Shares	34,381,000	33,635,000

Statement of Stockholders' Equi

Statement of Stockholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	AOCI Attributable to Parent	Noncontrolling Interests
Common Stock, Shares, Issued		378,597
Common Stock, Value, Issued		$ 473
Additional Paid in Capital			$ 594
Treasury Stock, Shares				27,491
Treasury Stock, Value				$ (3,288)
Retained Earnings					$ 5,769
Accumulated Other Comprehensive Income (Loss)						$ 2,919
Noncontrolling Interests							$ 253
Stockholders' Equity Attributable to Parent	$ 882
Net income	562				548
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest							12
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share	560
Other Comprehensive Income, Net of Tax	157					147	(10)
Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share	(157)
Stock-based awards exercised or vested	24		(79)	$ 103
Treasury Stock, Shares, Acquired				4,129
Treasury Stock, Value, Acquired, Cost Method				$ (447)
Recognition of stock-based compensation	25		25
Dividends, Common Stock, Cash	(719)				(699)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders							(20)
Other	(10)		2		164	(156)
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures				(907)
Common Stock, Shares, Issued		378,597
Common Stock, Value, Issued		$ 473
Additional Paid in Capital			589
Treasury Stock, Shares				29,001
Treasury Stock, Value				$ (3,460)
Retained Earnings					5,520
Accumulated Other Comprehensive Income (Loss)						2,805
Noncontrolling Interests							238
Stockholders' Equity Attributable to Parent	555
Net income	465				455
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest							9
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share	464
Other Comprehensive Income, Net of Tax	273					262	(11)
Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share	(273)
Stock-based awards exercised or vested	10		(54)	$ 64			0
Treasury Stock, Shares, Acquired				2,280
Treasury Stock, Value, Acquired, Cost Method				$ (236)
Recognition of stock-based compensation	8		8
Dividends, Common Stock, Cash	(349)				(349)
Other	1				156	(155)	(1)
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures				(568)
Common Stock, Shares, Issued		378,597
Common Stock, Value, Issued		$ 473
Additional Paid in Capital			542
Treasury Stock, Shares				30,713
Treasury Stock, Value				$ (3,632)
Retained Earnings					5,782
Accumulated Other Comprehensive Income (Loss)						3,222
Noncontrolling Interests							235
Stockholders' Equity Attributable to Parent	178
Common Stock, Shares, Issued		378,597
Common Stock, Value, Issued	473	$ 473
Additional Paid in Capital	$ 548		548
Treasury Stock, Shares	33,635,000,000			33,635
Treasury Stock, Value	$ (3,956)			$ (3,956)
Retained Earnings	5,947				5,947
Accumulated Other Comprehensive Income (Loss)	3,299					3,299
Noncontrolling Interests	241						241
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	(46)
Stockholders' Equity Attributable to Parent	(287)
Net income	961				939
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest							20
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share	959
Other Comprehensive Income, Net of Tax	(24)					(30)	(7)
Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share	23
Stock-based awards exercised or vested	160		(87)	$ 247
Treasury Stock, Shares, Acquired				2,905
Treasury Stock, Value, Acquired, Cost Method				$ (353)
Recognition of stock-based compensation	48		48
Dividends, Common Stock, Cash	(733)				(709)
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders							(24)
Other	8		1		(7)		(2)
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures				(2,159)
Common Stock, Shares, Issued		378,597
Common Stock, Value, Issued		$ 473
Additional Paid in Capital			538
Treasury Stock, Shares				34,657
Treasury Stock, Value				$ (4,075)
Retained Earnings					6,048
Accumulated Other Comprehensive Income (Loss)						3,289
Noncontrolling Interests							223
Stockholders' Equity Attributable to Parent	(82)
Net income	495				485
Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest							9
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excludes Redeemable Interests' Share	494
Other Comprehensive Income, Net of Tax	(19)					(20)	(2)
Other Comprehensive Income (Loss), Net of Tax, Excludes Redeemable Interests' Share	18
Stock-based awards exercised or vested	132		(60)	$ 192
Treasury Stock, Shares, Acquired				1,396
Treasury Stock, Value, Acquired, Cost Method				$ (179)
Recognition of stock-based compensation	31		31
Dividends, Common Stock, Cash	(355)				(355)
Other	9		1		(8)		(2)
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures				(1,672)
Common Stock, Shares, Issued		378,597
Common Stock, Value, Issued	473	$ 473
Additional Paid in Capital	$ 510		$ 510
Treasury Stock, Shares	34,381,000,000			34,381
Treasury Stock, Value	$ (4,062)			$ (4,062)
Retained Earnings	6,170				$ 6,170
Accumulated Other Comprehensive Income (Loss)	3,269					$ 3,269
Noncontrolling Interests	228						$ 228
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	50
Stockholders' Equity Attributable to Parent	$ (178)

Statement of Stockholders' Eq_2

Statement of Stockholders' Equity Stockholders' Equity Parentheticals - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Statement of Stockholders' Equity [Abstract]
Dividends declared	$ 1.03	$ 1	$ 2.06	$ 2

Consolidated Cash Flow Statemen

Consolidated Cash Flow Statement - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Operating Activities
Net income	$ 961	$ 562
Depreciation and amortization	470	435
Asset impairments	0	74
Stock-based compensation	48	26
Deferred income taxes	26	17
Net losses on asset dispositions	17	53
Equity companies' earnings in excess of dividends paid	(30)	(25)
Operating working capital	(525)	93
Postretirement benefits	(21)	(14)
Other	(20)	108
Cash Provided by Operations	926	1,329
Investing Activities
Capital spending	(569)	(347)
Investments in time deposits	(186)	(147)
Maturities of time deposits	229	94
Other	4	(12)
Cash Used for Investing	(522)	(412)
Financing Activities
Cash dividends paid	(700)	(691)
Change in short-term debt	543	104
Debt Proceeds	696	0
Debt repayments	(703)	(4)
Proceeds from exercise of stock options	160	22
Acquisitions of common stock for the treasury	(330)	(420)
Other	(79)	(41)
Cash Used for Financing	(413)	(1,030)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	4	(19)
Change in Cash and Cash Equivalents	(5)	(132)
Cash and Cash Equivalents - Beginning of Period	539	616
Cash and Cash Equivalents - End of Period	$ 534	$ 484

Accounting Policies

Accounting Policies	6 Months Ended
	Jun. 30, 2019
Accounting Policies [Abstract]
Accounting Policies	Accounting Policies Basis of Presentation The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all material adjustments which are of a normal and recurring nature necessary for a fair presentation of the results for the periods presented have been reflected. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted. For further information, refer to the consolidated financial statements and footnotes included in our Annual Report on Form 10‑K for the year ended December 31, 2018 . The terms "Corporation," "Kimberly-Clark," "K-C," "we," "our" and "us" refer to Kimberly-Clark Corporation and its consolidated subsidiaries. Highly Inflationary Accounting in Argentina GAAP guidance requires the use of highly inflationary accounting for countries whose cumulative three-year inflation exceeds 100 percent. In the second quarter of 2018, published inflation indices indicated that the three-year cumulative inflation in Argentina exceeded 100 percent, and as of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiaries in Argentina (“K-C Argentina”). Under highly inflationary accounting, K-C Argentina’s functional currency became the U.S. dollar, and its income statement and balance sheet have been measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material. As of June 30, 2019, K-C Argentina had a small net peso monetary position. Net sales of K-C Argentina were less than 2 percent of our consolidated net sales for the six months ended June 30, 2019 and 2018. Leases Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments made and exclude lease incentives. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. Variable lease payments are generally expensed as incurred and include certain index-based changes in rent, certain nonlease components, such as maintenance and other services provided by the lessor, and other charges included in the lease. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term. Lease agreements with lease and nonlease components are combined as a single lease component. The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Recently Adopted Accounting Standards The Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2016-02, Leases (Topic 842), amended by ASU 2018-11, Leases (Topic 842): Targeted Improvements . The new guidance requires a lessee to recognize assets and liabilities for all leases with lease terms of more than 12 months and provide additional disclosures. The ASU requires adoption using a modified retrospective transition approach with either 1) periods prior to the adoption date being recast or 2) a cumulative-effect adjustment recognized to the opening balance of retained earnings on the adoption date with prior periods not recast. We adopted this standard on January 1, 2019 using the cumulative-effect adjustment approach. We elected the package of practical expedients in transition for leases that commenced prior to January 1, 2019 whereby these contracts were not reassessed or reclassified from their previous assessment as of December 31, 2018. We also elected certain other practical expedients in transition including not reassessing existing land easements as lease contracts. For all new and modified leases after adoption of the ASU, we have taken the component election allowing us to account for lease components together with nonlease components in the calculation of the lease asset and corresponding liability. We implemented processes and a lease accounting system to ensure adequate internal controls were in place to assess our contracts and enable proper accounting and reporting of financial information upon adoption. No cumulative-effect adjustment was recognized as the amount was not material, and the impact on our results of operations and cash flows was also not material. See Note 7 for the financial position impact and additional disclosures. The FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities . The new standard makes more financial and non-financial hedging strategies eligible for hedge accounting. It also amends presentation and disclosure requirements and changes how companies assess hedge effectiveness. This ASU requires adoption using a modified retrospective transition approach with a cumulative-effect adjustment recognized to the opening balance of retained earnings on the adoption date with prior periods not recast. We adopted this standard on January 1, 2019 with no cumulative-effect adjustment as the amount was not material. The effects of this standard on our financial position, results of operations and cash flows were not material. Accounting Standards Issued - Not Yet Adopted The FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) . The new guidance modifies disclosure requirements related to fair value measurement. The amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Implementation on a prospective or retrospective basis varies by specific disclosure requirement. Early adoption is permitted. The standard also allows for early adoption of any removed or modified disclosures upon issuance of this ASU while delaying adoption of the additional disclosures until their effective date. The FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40). The new guidance reduces complexity for the accounting for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). For public companies, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted. Implementation should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The effects of this standard on our financial position, results of operations or cash flows are not expected to be material.

2018 Global Restructuring Progr

2018 Global Restructuring Program	6 Months Ended
	Jun. 30, 2019
2018 Global Restructuring Program
Restructuring Cost and Reserve
Restructuring and Related Activities Disclosure	2018 Global Restructuring Program In January 2018, we announced the 2018 Global Restructuring Program to reduce our structural cost base by streamlining and simplifying our manufacturing supply chain and overhead organization. We expect to close or sell approximately 10 manufacturing facilities and expand production capacity at several others. We expect to exit or divest some lower-margin businesses that generate approximately 1 percent of our net sales. The sales are concentrated in our consumer tissue business segment. The restructuring is expected to impact our organizations in all major geographies. Workforce reductions are expected to be in the range of 5,000 to 5,500 . Certain capital appropriations under the 2018 Global Restructuring Program are being finalized. Accounting for actions related to each appropriation will commence when the appropriation is authorized for execution. The restructuring is expected to be completed by the end of 2020 , with total costs anticipated to be $1.7 billion to $1.9 billion pre-tax ( $1.35 billion to $1.5 billion after tax). Cash costs are expected to be $900 to $1.0 billion, primarily related to workforce reductions. Non-cash charges are expected to be $800 to $900 pre-tax and will primarily consist of incremental depreciation, asset write-offs and pension settlement and curtailment charges. Restructuring charges in 2019 are expected to be $400 to $500 pre-tax ( $320 to $400 after tax). The following charges were incurred in connection with the 2018 Global Restructuring Program: Three Months Ended Six Months Ended 2019 2018 2019 2018 Cost of products sold: Charges for workforce reductions $ 2 $ 6 $ 32 $ 125 Asset impairments — — — 74 Asset write-offs 15 31 27 86 Incremental depreciation 65 40 132 68 Other exit costs 20 8 36 9 Total 102 85 227 362 Marketing, research and general expenses: Charges for workforce reductions (12 ) (16 ) (8 ) 270 Other exit costs 29 31 53 45 Total 17 15 45 315 Other (income) and expense, net — — (1 ) — Nonoperating expense (a) — 30 — 30 Total charges 119 130 271 707 Provision for income taxes (27 ) (24 ) (58 ) (167 ) Net charges 92 106 213 540 Net impact related to equity companies and noncontrolling interests — (4 ) 1 (10 ) Net charges attributable to Kimberly-Clark Corporation $ 92 $ 102 $ 214 $ 530 (a) Represents non-cash pension settlement charges resulting from restructuring actions. The asset impairment charges were measured based on the excess of the carrying value of the impacted asset groups over their fair values. These fair values were measured by using discounted cash flows expected over the limited time the assets would remain in use and as a result, the assets were essentially written off. The use of discounted cash flows represents a level 3 measure under the fair value hierarchy. The following summarizes the restructuring liabilities activity: 2019 2018 Restructuring liabilities at January 1 $ 210 $ — Charges for workforce reductions and other cash exit costs 112 446 Cash payments (142 ) (158 ) Currency and other 6 (13 ) Restructuring liabilities at June 30 $ 186 $ 275 Restructuring liabilities of $125 and $157 are recorded in Accrued expenses and other current liabilities and $61 and $118 are recorded in Other Liabilities as of June 30, 2019 and 2018, respectively. The impact related to restructuring charges is recorded in Operating working capital and Other Operating Activities, as appropriate, in our consolidated cash flow statements. Through June 30, 2019 , cumulative pre-tax charges for the 2018 Global Restructuring Program were $1.3 billion ( $1.0

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Income Tax Disclosure	Income Taxes On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "Tax Act"). In the period ended December 31, 2017, we recorded a provisional discrete net tax benefit related to the transition tax, remeasurement of deferred taxes, our reassessment of permanently reinvested earnings, uncertain tax positions and valuation allowances, and actions taken in anticipation of the Tax Act. The provisional amounts recorded in 2017 were finalized in 2018. During 2018, we recorded discrete net tax expense related to new guidance issued during 2018 affecting tax benefits we recorded in the period ended December 31, 2017 for the transition tax and certain tax planning actions taken in anticipation of the Tax Act. At December 31, 2018, we finalized our policy and elected to use the period cost method for global intangible low-taxed income (“GILTI”) provisions and therefore have not recorded deferred taxes for basis differences expected to reverse in future periods. In the first quarter of 2018, we recorded discrete net tax expense of $82 primarily related to guidance issued affecting tax benefits we recorded in the fourth quarter of 2017 for certain tax planning actions taken in anticipation of the Tax Act. The Brazilian tax authority, Secretaria da Receita Federal do Brasil ("RFB"), concluded an audit for the taxable periods from 2008-2013. This audit included a review of our determinations of amortization of certain goodwill arising from prior acquisitions in Brazil, and the RFB has proposed adjustments that effectively eliminate the goodwill amortization benefits related to these transactions. Administrative appeals have been exhausted, and the dispute is moving into the judicial phase. The amount of the proposed tax adjustments and penalties is approximately $90 as of June 30, 2019 (translated at the June 30, 2019 currency exchange rate). The amount ultimately in dispute will be significantly greater because of interest. We believe we have meritorious defenses and intend to vigorously defend these proposed adjustments; however, it is expected to take a number of years to reach resolution of this matter.

Fair Value Information

Fair Value Information	6 Months Ended
	Jun. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value Information	Fair Value Information The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are: Level 1 – Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities. Level 2 – Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly. Level 3 – Prices or valuations that require inputs that are significant to the valuation and are unobservable. A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. During the six months ended June 30, 2019 and for the full year 2018 , there were no significant transfers among level 1, 2, or 3 fair value determinations. Derivative assets and liabilities are measured on a recurring basis at fair value. At June 30, 2019 and December 31, 2018 , derivative assets were $31 and $30 , respectively, and derivative liabilities were $34 and $18 , respectively. The fair values of derivatives used to manage interest rate risk and commodity price risk are based on LIBOR rates and interest rate swap curves and NYMEX price quotations, respectively. The fair values of hedging instruments used to manage foreign currency risk are based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Measurement of our derivative assets and liabilities is considered a level 2 measurement. Additional information on our classification and use of derivative instruments is contained in Note 8 . Redeemable preferred securities of subsidiaries are measured on a recurring basis at fair value and were $38 and $64 at June 30, 2019 and December 31, 2018 , respectively. They are not traded in active markets. As of June 30, 2019, the fair values of the redeemable securities were based on a discounted cash flow valuation model. Measurement of the redeemable preferred securities is considered a level 3 measurement. Company-owned life insurance ("COLI") assets are measured on a recurring basis at fair value. COLI assets were $71 and $64 at June 30, 2019 and December 31, 2018 , respectively. The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in Other Assets. The COLI policies are measured at fair value using the net asset value per share practical expedient, and therefore, are not classified in the fair value hierarchy. The following table includes the fair value of our financial instruments for which disclosure of fair value is required: Fair Value Hierarchy Level Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value June 30, 2019 December 31, 2018 Assets Cash and cash equivalents (a) 1 $ 534 $ 534 $ 539 $ 539 Time deposits (b) 1 204 204 256 256 Liabilities Short-term debt (c) 2 1,031 1,031 495 495 Long-term debt (d) 2 6,961 7,668 6,960 7,192 (a) Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. (b) Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value. (c) Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value. (d) Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2019
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share ("EPS") There are no adjustments required to be made to net income for purposes of computing EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows: Three Months Ended Six Months Ended (Millions of shares) 2019 2018 2019 2018 Basic 344.2 348.8 344.3 349.6 Dilutive effect of stock options and restricted share unit awards 1.8 1.5 1.7 1.7 Diluted 346.0 350.3 346.0 351.3 The impact of options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares was insignificant. The number of common shares outstanding as of June 30, 2019 and 2018 was 344.2 million and 347.9 million , respectively.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in Accumulated Other Comprehensive Income ("AOCI"). For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation. Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments. The change in net unrealized currency translation for the six months ended June 30, 2019 was primarily due to strengthening of foreign currencies versus the U.S. dollar. The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2017 $ (1,864 ) $ (976 ) $ (39 ) $ (40 ) Other comprehensive income (loss) before reclassifications (254 ) 27 13 15 (Income) loss reclassified from AOCI 1 39 (a) (1 ) (a) 13 Net current period other comprehensive income (loss) (253 ) 66 12 28 Tax effects reclassified from AOCI (18 ) (125 ) (5 ) (8 ) Balance as of June 30, 2018 $ (2,135 ) $ (1,035 ) $ (32 ) $ (20 ) Balance as of December 31, 2018 $ (2,297 ) $ (1,017 ) $ 12 $ 3 Other comprehensive income (loss) before reclassifications 29 1 15 (12 ) (Income) loss reclassified from AOCI — 6 (a) (1 ) (a) (8 ) Net current period other comprehensive income (loss) 29 7 14 (20 ) Balance as of June 30, 2019 $ (2,268 ) $ (1,010 ) $ 26 $ (17 ) (a) Included in computation of net periodic benefit costs.

Leases

Leases	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
Leases of Lessee Disclosure	Leases We have entered into leases for certain facilities, vehicles, material handling and other equipment. Our leases have remaining contractual terms up to 19 years, some of which include options to extend the leases for up to 20 years, and some of which include options to terminate the leases within 1 year. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Our operating lease costs are primarily related to facility leases for inventory warehousing and administration offices, and our finance leases are immaterial. Operating Lease Cost Three Months Ended Six Months Ended Income Statement Classification Lease cost $ 40 $ 79 Cost of products sold, Marketing, research and general expenses Variable lease cost (a) 35 72 Cost of products sold, Marketing, research and general expenses Total lease cost $ 75 $ 151 (a) Includes short-term leases, which are immaterial. Operating Lease Assets and Liabilities June 30, 2019 Balance Sheet Classification Lease assets $ 416 Other Assets Current lease liabilities $ 136 Accrued expenses and other current liabilities Noncurrent lease liabilities 291 Other Liabilities Total lease liabilities $ 427 Maturity of Operating Lease Liabilities June 30, 2019 2019 $ 79 2020 133 2021 90 2022 63 2023 44 Thereafter 74 Total lease payments 483 Less imputed interest 56 Present value of lease liabilities $ 427 As of June 30, 2019, our operating leases have a weighted-average remaining lease term of 4.4 years and a weighted-average discount rate of 5.2 percent. Cash paid for amounts included in the measurement of operating lease liabilities was $80 for the six months ended June 30, 2019. As of June 30, 2019, we have additional operating leases, primarily for facilities, that have not yet commenced of $96 . These operating leases will commence during 2020 with lease terms of 7 years. The future minimum obligations under operating leases in effect as of December 31, 2018 having a noncancelable term in excess of one year as determined prior to the adoption of ASU 842 are as follows: December 31, 2018 2019 $ 160 2020 123 2021 85 2022 57 2023 41 Thereafter 72 Future minimum obligations $ 538

Objectives And Strategies For U

Objectives And Strategies For Using Derivatives	6 Months Ended
	Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Objectives And Strategies For Using Derivatives	Objectives and Strategies for Using Derivatives As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest rates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing activities and, where appropriate, the use of derivative instruments. We enter into derivative instruments to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The foreign currency exposure on certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments. Interest rate risk is managed using a portfolio of variable and fixed-rate debt composed of short and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable and fixed-rate debt and are designated and qualify as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt, and these contracts are designated as cash flow hedges. We use derivative instruments, such as forward contracts, to hedge a limited portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months. Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowings. A portion of our balance sheet translation exposure for certain affiliates, which results from changes in translation rates between the affiliates’ functional currencies and the U.S. dollar, is hedged with cross-currency swap contracts and certain foreign denominated debt. These instruments are designated as net investment hedges and have an aggregate notional value of $1.5 billion at June 30, 2019 . We exclude the interest accruals on cross-currency swap contracts and the forward points on foreign exchange forward contracts from the assessment and measurement of hedge effectiveness. We recognize the interest accruals on cross-currency swap contracts in earnings within Interest expense. We amortize the forward points on foreign exchange contracts into earnings within Interest expense over the life of the hedging relationship. Changes in fair value of net investment hedges are recorded in AOCI and offset the change in the value of the net investment being hedged. For the six months ended June 30, 2019, no significant unrealized gains or losses related to net investment hedge fair value changes were recorded in AOCI and no significant amounts were reclassified from AOCI to Interest expense. At June 30, 2019 and December 31, 2018 , derivative assets were $31 and $30 , respectively, and derivative liabilities were $34 and $18 , respectively, primarily comprised of foreign currency exchange contracts. Derivative assets are recorded in Other current assets or Other Assets, as appropriate, and derivative liabilities are recorded in Accrued expenses and other current liabilities or Other Liabilities, as appropriate. Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these interest rate derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in Interest expense. The offset to the change in fair values of the related debt is also recorded in Interest expense. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to Interest expense over the life of the related debt. As of June 30, 2019 , the aggregate notional values and carrying values of outstanding interest rate contracts designated as fair value hedges were $300 and $308 , respectively. For the six months ended June 30, 2019 and 2018, gains or losses recognized in Interest expense for interest rate swaps were not significant. For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same income statement line and period that the hedged exposure affects earnings. As of June 30, 2019 , outstanding commodity forward contracts were in place to hedge a limited portion of our estimated requirements of the related underlying commodities in the remainder of 2019 and future periods. As of June 30, 2019 , the aggregate notional value of outstanding foreign exchange derivative contracts designated as cash flow hedges were $657 . For the six months ended June 30, 2019 and 2018, no significant gains or losses were reclassified into Interest expense, Cost of products sold or Other (income) and expense, net as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring. At June 30, 2019 , amounts to be reclassified from AOCI into Interest expense, Cost of products sold or Other (income) and expense, net during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at June 30, 2019 is June 2021 . No significant amounts were excluded from the assessment of net investment, fair value or cash flow hedge effectiveness as of June 30, 2019. Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in Other (income) and expense, net. Losses of $5 and $40 were recorded in the three months ended June 30, 2019 and 2018 , respectively. Losses of $13 and $37 were recorded in the six months ended June 30, 2019 and 2018 , respectively. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At June 30, 2019 , the notional value of these undesignated derivative instruments was approximately $1.7 billion .

Description Of Business Segment

Description Of Business Segments	6 Months Ended
	Jun. 30, 2019
Segment Reporting [Abstract]
Business Segment Information	Business Segment Information We are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments: Personal Care, Consumer Tissue and K-C Professional. The reportable segments were determined in accordance with how our chief operating decision maker and our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes Other (income) and expense, net and income and expense not associated with ongoing operations of the business segments, including the costs of corporate decisions related to the 2018 Global Restructuring Program described in Note 2. The principal sources of revenue in each global business segment are described below: • Personal Care brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise and other brand names. • Consumer Tissue offers a wide variety of innovative solutions and trusted brands that responsibly improve everyday living for families around the world. Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve and other brand names. • K-C Professional partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and KleenGuard are well known for quality and trusted to help people around the world work better. Information concerning consolidated operations by business segment is presented in the following tables: Three Months Ended June 30 Six Months Ended June 30 2019 2018 Change 2019 2018 Change NET SALES Personal Care $ 2,286 $ 2,257 +1 % $ 4,561 $ 4,564 — Consumer Tissue 1,472 1,472 — 2,998 3,051 -2 % K-C Professional 821 861 -5 % 1,638 1,693 -3 % Corporate & Other 15 14 N.M. 30 27 N.M. TOTAL NET SALES $ 4,594 $ 4,604 — $ 9,227 $ 9,335 -1 % OPERATING PROFIT Personal Care $ 485 $ 461 +5 % $ 969 $ 931 +4 % Consumer Tissue 221 207 +7 % 462 456 +1 % K-C Professional 162 165 -2 % 312 323 -3 % Corporate & Other (a) (193 ) (149 ) N.M. (409 ) (781 ) N.M. Other (income) and expense, net (a) 5 10 -50 % 9 8 +13 % TOTAL OPERATING PROFIT $ 670 $ 674 -1 % $ 1,325 $ 921 +44 % (a) Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including charges related to the 2018 Global Restructuring Program. Restructuring charges related to the personal care, consumer tissue and K-C Professional business segments were $66 , $36 and $15 , respectively, for the three months ended June 30, 2019, $87 , $18 and $6 , respectively, for the three months ended June 30, 2018, $155 , $82 and $31 , respectively, for the six months ended June 30, 2019 and $401 , $159 and $101 , respectively, for the six months ended June 30, 2018. N.M. - Not Meaningful Sales of Principal Products Three Months Ended June 30 Six Months Ended June 30 (Billions of dollars) 2019 2018 2019 2018 Consumer tissue products $ 1.5 $ 1.5 $ 3.0 $ 3.1 Baby and child care products 1.6 1.6 3.1 3.2 Away-from-home professional products 0.8 0.9 1.6 1.7 All other 0.7 0.6 1.5 1.3 Consolidated $ 4.6 $ 4.6 $ 9.2 $ 9.3

Supplemental Balance Sheet Data

Supplemental Balance Sheet Data	6 Months Ended
	Jun. 30, 2019
Statement of Financial Position [Abstract]
Additional Financial Information Disclosure	Supplemental Balance Sheet Data The following schedule presents a summary of inventories by major class: June 30, 2019 December 31, 2018 LIFO Non-LIFO Total LIFO Non-LIFO Total Raw materials $ 88 $ 249 $ 337 $ 99 $ 263 $ 362 Work in process 134 96 230 120 94 214 Finished goods 485 718 1,203 461 692 1,153 Supplies and other — 267 267 — 275 275 707 1,330 2,037 680 1,324 2,004 Excess of FIFO or weighted-average cost over LIFO cost (181 ) — (181 ) (191 ) — (191 ) Total $ 526 $ 1,330 $ 1,856 $ 489 $ 1,324 $ 1,813 Inventories are valued at the lower of cost or net realizable value, determined on the FIFO or weighted-average cost methods, and at the lower of cost or market, determined on the LIFO cost method. The following schedule presents a summary of property, plant and equipment, net: June 30, 2019 December 31, 2018 Land $ 169 $ 169 Buildings 2,831 2,787 Machinery and equipment 14,212 14,059 Construction in progress 760 699 17,972 17,714 Less accumulated depreciation (10,765 ) (10,555 ) Total $ 7,207 $ 7,159

2018 Global Restructuring Pro_2

2018 Global Restructuring Program (Tables) - 2018 Global Restructuring Program	6 Months Ended
	Jun. 30, 2019
Restructuring Cost and Reserve
Restructuring and Related Costs	The following charges were incurred in connection with the 2018 Global Restructuring Program: Three Months Ended Six Months Ended 2019 2018 2019 2018 Cost of products sold: Charges for workforce reductions $ 2 $ 6 $ 32 $ 125 Asset impairments — — — 74 Asset write-offs 15 31 27 86 Incremental depreciation 65 40 132 68 Other exit costs 20 8 36 9 Total 102 85 227 362 Marketing, research and general expenses: Charges for workforce reductions (12 ) (16 ) (8 ) 270 Other exit costs 29 31 53 45 Total 17 15 45 315 Other (income) and expense, net — — (1 ) — Nonoperating expense (a) — 30 — 30 Total charges 119 130 271 707 Provision for income taxes (27 ) (24 ) (58 ) (167 ) Net charges 92 106 213 540 Net impact related to equity companies and noncontrolling interests — (4 ) 1 (10 ) Net charges attributable to Kimberly-Clark Corporation $ 92 $ 102 $ 214 $ 530 (a) Represents non-cash pension settlement charges resulting from restructuring actions.
Restructuring Reserve
Schedule of Restructuring Reserve by Type of Cost	The following summarizes the restructuring liabilities activity: 2019 2018 Restructuring liabilities at January 1 $ 210 $ — Charges for workforce reductions and other cash exit costs 112 446 Cash payments (142 ) (158 ) Currency and other 6 (13 ) Restructuring liabilities at June 30 $ 186 $ 275

Fair Value Information (Tables)

Fair Value Information (Tables)	6 Months Ended
	Jun. 30, 2019
Fair Value Disclosures [Abstract]
Fair value of financial instruments	The following table includes the fair value of our financial instruments for which disclosure of fair value is required: Fair Value Hierarchy Level Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value June 30, 2019 December 31, 2018 Assets Cash and cash equivalents (a) 1 $ 534 $ 534 $ 539 $ 539 Time deposits (b) 1 204 204 256 256 Liabilities Short-term debt (c) 2 1,031 1,031 495 495 Long-term debt (d) 2 6,961 7,668 6,960 7,192 (a) Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value. (b) Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value. (c) Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value. (d) Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2019
Earnings Per Share [Abstract]
Average Common Shares Outstanding Basic and Diluted	The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows: Three Months Ended Six Months Ended (Millions of shares) 2019 2018 2019 2018 Basic 344.2 348.8 344.3 349.6 Dilutive effect of stock options and restricted share unit awards 1.8 1.5 1.7 1.7 Diluted 346.0 350.3 346.0 351.3

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2019
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss), Attributable to Kimberly-Clark Corporation	The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows: Unrealized Translation Defined Benefit Pension Plans Other Postretirement Benefit Plans Cash Flow Hedges and Other Balance as of December 31, 2017 $ (1,864 ) $ (976 ) $ (39 ) $ (40 ) Other comprehensive income (loss) before reclassifications (254 ) 27 13 15 (Income) loss reclassified from AOCI 1 39 (a) (1 ) (a) 13 Net current period other comprehensive income (loss) (253 ) 66 12 28 Tax effects reclassified from AOCI (18 ) (125 ) (5 ) (8 ) Balance as of June 30, 2018 $ (2,135 ) $ (1,035 ) $ (32 ) $ (20 ) Balance as of December 31, 2018 $ (2,297 ) $ (1,017 ) $ 12 $ 3 Other comprehensive income (loss) before reclassifications 29 1 15 (12 ) (Income) loss reclassified from AOCI — 6 (a) (1 ) (a) (8 ) Net current period other comprehensive income (loss) 29 7 14 (20 ) Balance as of June 30, 2019 $ (2,268 ) $ (1,010 ) $ 26 $ (17 ) (a) Included in computation of net periodic benefit costs.

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2019
Leases [Abstract]
Lease, Cost	Operating Lease Cost Three Months Ended Six Months Ended Income Statement Classification Lease cost $ 40 $ 79 Cost of products sold, Marketing, research and general expenses Variable lease cost (a) 35 72 Cost of products sold, Marketing, research and general expenses Total lease cost $ 75 $ 151 (a) Includes short-term leases, which are immaterial.
Schedule of Lease Assets and Liabilities	Operating Lease Assets and Liabilities June 30, 2019 Balance Sheet Classification Lease assets $ 416 Other Assets Current lease liabilities $ 136 Accrued expenses and other current liabilities Noncurrent lease liabilities 291 Other Liabilities Total lease liabilities $ 427
Lessee, Operating Lease, Liability, Maturity	Maturity of Operating Lease Liabilities June 30, 2019 2019 $ 79 2020 133 2021 90 2022 63 2023 44 Thereafter 74 Total lease payments 483 Less imputed interest 56 Present value of lease liabilities $ 427
Schedule of Future Minimum Rental Payments for Operating Leases	The future minimum obligations under operating leases in effect as of December 31, 2018 having a noncancelable term in excess of one year as determined prior to the adoption of ASU 842 are as follows: December 31, 2018 2019 $ 160 2020 123 2021 85 2022 57 2023 41 Thereafter 72 Future minimum obligations $ 538

Description Of Business Segme_2

Description Of Business Segments (Tables)	6 Months Ended
	Jun. 30, 2019
Revenue from External Customer
Information Concerning Consolidated Operations by Business Segment	Information concerning consolidated operations by business segment is presented in the following tables: Three Months Ended June 30 Six Months Ended June 30 2019 2018 Change 2019 2018 Change NET SALES Personal Care $ 2,286 $ 2,257 +1 % $ 4,561 $ 4,564 — Consumer Tissue 1,472 1,472 — 2,998 3,051 -2 % K-C Professional 821 861 -5 % 1,638 1,693 -3 % Corporate & Other 15 14 N.M. 30 27 N.M. TOTAL NET SALES $ 4,594 $ 4,604 — $ 9,227 $ 9,335 -1 % OPERATING PROFIT Personal Care $ 485 $ 461 +5 % $ 969 $ 931 +4 % Consumer Tissue 221 207 +7 % 462 456 +1 % K-C Professional 162 165 -2 % 312 323 -3 % Corporate & Other (a) (193 ) (149 ) N.M. (409 ) (781 ) N.M. Other (income) and expense, net (a) 5 10 -50 % 9 8 +13 % TOTAL OPERATING PROFIT $ 670 $ 674 -1 % $ 1,325 $ 921 +44 % (a) Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including charges related to the 2018 Global Restructuring Program. Restructuring charges related to the personal care, consumer tissue and K-C Professional business segments were $66 , $36 and $15 , respectively, for the three months ended June 30, 2019, $87 , $18 and $6 , respectively, for the three months ended June 30, 2018, $155 , $82 and $31 , respectively, for the six months ended June 30, 2019 and $401 , $159 and $101 , respectively, for the six months ended June 30, 2018. N.M. - Not Meaningful
Sales of Principal Products	Sales of Principal Products Three Months Ended June 30 Six Months Ended June 30 (Billions of dollars) 2019 2018 2019 2018 Consumer tissue products $ 1.5 $ 1.5 $ 3.0 $ 3.1 Baby and child care products 1.6 1.6 3.1 3.2 Away-from-home professional products 0.8 0.9 1.6 1.7 All other 0.7 0.6 1.5 1.3 Consolidated $ 4.6 $ 4.6 $ 9.2 $ 9.3

Summary of Balance Sheet Data (

Summary of Balance Sheet Data (Tables)	6 Months Ended
	Jun. 30, 2019
Statement of Financial Position [Abstract]
Schedule of Inventory, Current	The following schedule presents a summary of inventories by major class: June 30, 2019 December 31, 2018 LIFO Non-LIFO Total LIFO Non-LIFO Total Raw materials $ 88 $ 249 $ 337 $ 99 $ 263 $ 362 Work in process 134 96 230 120 94 214 Finished goods 485 718 1,203 461 692 1,153 Supplies and other — 267 267 — 275 275 707 1,330 2,037 680 1,324 2,004 Excess of FIFO or weighted-average cost over LIFO cost (181 ) — (181 ) (191 ) — (191 ) Total $ 526 $ 1,330 $ 1,856 $ 489 $ 1,324 $ 1,813
Property, Plant and Equipment	The following schedule presents a summary of property, plant and equipment, net: June 30, 2019 December 31, 2018 Land $ 169 $ 169 Buildings 2,831 2,787 Machinery and equipment 14,212 14,059 Construction in progress 760 699 17,972 17,714 Less accumulated depreciation (10,765 ) (10,555 ) Total $ 7,207 $ 7,159

Accounting Policies Narrative (

Accounting Policies Narrative (Details)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Net sales | K-C Argentina
Accounting Policies
Net sales of K-C Argentina, percent	2.00%	2.00%

2018 Global Restructuring Pro_3

2018 Global Restructuring Program Narrative (Details) - 2018 Global Restructuring Program $ in Millions	3 Months Ended		6 Months Ended		18 Months Ended	36 Months Ended
	Jun. 30, 2019USD ($)	Jun. 30, 2018USD ($)	Jun. 30, 2019USD ($)	Jun. 30, 2018USD ($)	Jun. 30, 2019USD ($)	Dec. 31, 2020USD ($)Employee	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)
Restructuring Cost and Reserve
Restructuring Reserve	$ 186	$ 275	$ 186	$ 275	$ 186			$ 210	$ 0
Payments for Restructuring			(142)	(158)
After Tax
Restructuring Cost and Reserve
Restructuring Charges	92	106	213	540	1
Before Tax
Restructuring Cost and Reserve
Restructuring Charges	119	130	271	707	1,300
Accrued Expenses
Restructuring Cost and Reserve
Restructuring Reserve	125	157	125	157	125
Other current liabilities
Restructuring Cost and Reserve
Restructuring Reserve	$ 61	$ 118	$ 61	$ 118	$ 61
Minimum | Scenario, Forecast
Restructuring Cost and Reserve
Expected Number of Positions Eliminated | Employee						5,000
Minimum | After Tax | Scenario, Forecast
Restructuring Cost and Reserve
Restructuring and Related Cost, Expected Cost						$ 1,350	$ 320
Minimum | Before Tax | Scenario, Forecast
Restructuring Cost and Reserve
Restructuring and Related Cost, Expected Cost						1,700	400
Minimum | Cash charges | Scenario, Forecast
Restructuring Cost and Reserve
Restructuring and Related Cost, Expected Cost						900
Minimum | Non-cash charges | Before Tax | Scenario, Forecast
Restructuring Cost and Reserve
Restructuring and Related Cost, Expected Cost						$ 800
Maximum | Scenario, Forecast
Restructuring Cost and Reserve
Expected Number of Positions Eliminated | Employee						5,500
Maximum | After Tax | Scenario, Forecast
Restructuring Cost and Reserve
Restructuring and Related Cost, Expected Cost						$ 1,500	400
Maximum | Before Tax | Scenario, Forecast
Restructuring Cost and Reserve
Restructuring and Related Cost, Expected Cost						1,900	$ 500
Maximum | Cash charges | Scenario, Forecast
Restructuring Cost and Reserve
Restructuring and Related Cost, Expected Cost						1,000
Maximum | Non-cash charges | Before Tax | Scenario, Forecast
Restructuring Cost and Reserve
Restructuring and Related Cost, Expected Cost						$ 900

Restructuring and Related Activ

Restructuring and Related Activities (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		18 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019
Restructuring Cost and Reserve
Asset impairments			$ 0	$ 74
Provision for income taxes	$ (132)	$ (138)	(275)	(242)
2018 Global Restructuring Program
Restructuring Cost and Reserve
Provision for income taxes	(27)	(24)	(58)	(167)
2018 Global Restructuring Program | Charges for workforce reductions
Restructuring Cost and Reserve
Restructuring Charges			(112)	(446)
2018 Global Restructuring Program | Before Tax
Restructuring Cost and Reserve
Restructuring Charges	(119)	(130)	(271)	(707)	$ (1,300)
2018 Global Restructuring Program | After Tax
Restructuring Cost and Reserve
Restructuring Charges	(92)	(106)	(213)	(540)	$ (1)
2018 Global Restructuring Program | After Tax | Equity Companies and Noncontrolling Interests
Restructuring Cost and Reserve
Restructuring Charges	0	4	(1)	10
2018 Global Restructuring Program | After Tax | Kimberly-Clark Corporation
Restructuring Cost and Reserve
Restructuring Charges	(92)	(102)	(214)	(530)
2018 Global Restructuring Program | Cost of Sales | Before Tax
Restructuring Cost and Reserve
Charges (adjustments) for workforce reductions	2	6	32	125
Asset impairments	0	0	0	74
Incremental depreciation	65	40	132	68
Other exit costs	20	8	36	9
Restructuring Charges	(102)	(85)	(227)	(362)
2018 Global Restructuring Program | Cost of Sales | Before Tax | Asset write-offs
Restructuring Cost and Reserve
Restructuring Charges	(15)	(31)	(27)	(86)
2018 Global Restructuring Program | Marketing, Research and General Expenses | Before Tax
Restructuring Cost and Reserve
Charges (adjustments) for workforce reductions	(12)	(16)	(8)	270
Other exit costs	29	31	53	45
Restructuring Charges	(17)	(15)	(45)	(315)
2018 Global Restructuring Program | Other Income | Before Tax
Restructuring Cost and Reserve
Restructuring Charges	0	0	1	0
2018 Global Restructuring Program | Nonoperating Income (Expense) | Before Tax
Restructuring Cost and Reserve
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment	$ 0	$ 30	$ 0	$ 30

2018 Global Restructuring Pro_4

2018 Global Restructuring Program Restructuring Reserve (Details) - 2018 Global Restructuring Program - USD ($) $ in Millions	6 Months Ended		18 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019
Restructuring Cost and Reserve
Restructuring liabilities - January 1	$ 210	$ 0	$ 0
Cash payments	(142)	(158)
Currency and other	6	(13)
Restructuring liabilities - March 31	186	275	$ 186
Workforce reductions and other exit costs
Restructuring Cost and Reserve
Charges for workforce reductions and other cash exit costs	$ 112	$ 446

Income Taxes Income Taxes (Narr

Income Taxes Income Taxes (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2018	Jun. 30, 2019
U.S. Tax Cuts and Jobs Act
U.S. Tax Reform Related Matters
Discrete net tax expense	$ 82
Brazil Tax Matter
U.S. Tax Reform Related Matters
Proposed Tax Adjustments and Penalties, Foreign Tax Authority		$ 90

Fair Value Information (Narrati

Fair Value Information (Narrative) (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Redeemable Preferred Securities Of Subsidiaries Fair Value Disclosure	$ 38	$ 64
Fair Value, Measurements, Recurring | Net Asset Value or Its Equivalent
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Company-owned life insurance (“COLI”)	71	64
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Derivatives Assets	31	30
Derivatives Liability	$ 34	$ 18

Fair Value Information (Fair Va

Fair Value Information (Fair Value Of Financial Instruments) (Details) - USD ($) $ in Millions		Jun. 30, 2019	Dec. 31, 2018
Carrying (Reported) Amount, Fair Value Disclosure | Fair Value, Inputs, Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Cash and cash equivalents	[1]	$ 534	$ 539
Time deposits	[2]	204	256
Carrying (Reported) Amount, Fair Value Disclosure | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Short-term debt	[3]	1,031	495
Long-term debt	[4]	6,961	6,960
Estimated Fair Value, Fair Value Disclosure | Fair Value, Inputs, Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Cash and cash equivalents	[1]	534	539
Time deposits	[2]	204	256
Estimated Fair Value, Fair Value Disclosure | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Short-term debt	[3]	1,031	495
Long-term debt	[4]	$ 7,668	$ 7,192
[1]	Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
[2]	Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in Other current assets or Other Assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
[3]	Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
[4]	Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.

Earnings Per Share (Narrative)

Earnings Per Share (Narrative) (Details) - shares shares in Millions	Jun. 30, 2019	Jun. 30, 2018
Earnings Per Share [Abstract]
Common shares outstanding	344.2	347.9

Earnings Per Share (Average Com

Earnings Per Share (Average Common Shares Outstanding Basic And Diluted) (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Average Common Shares Outstanding Basic and Diluted
Basic	344.2	348.8	344.3	349.6
Dilutive effect of stock options and restricted share unit awards	1.8	1.5	1.7	1.7
Diluted	346	350.3	346	351.3

Stockholders' Equity (Component

Stockholders' Equity (Components of Accumulated Other Comprehensive Income) (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Net current period other comprehensive income (loss)		$ (4)	$ (381)	$ 22	$ (264)
Net current period other comprehensive income (loss)		26	79	22	79
Defined Benefit Pension Plans
Defined benefit and other postretirement benefit plans - Beginning balance				(1,017)	(976)
Other comprehensive income/(loss) before reclassifications				1	27
(Income)/loss reclassified from AOCI	[1]			6	39
Net current period other comprehensive income (loss)				7	66
Defined benefit and other postretirement benefit plans - Ending balance		(1,010)	(1,035)	(1,010)	(1,035)
Other Postretirement Benefit Plans
Defined benefit and other postretirement benefit plans - Beginning balance				12	(39)
Other comprehensive income/(loss) before reclassifications				15	13
(Income)/loss reclassified from AOCI	[1]			(1)	(1)
Net current period other comprehensive income (loss)				14	12
Defined benefit and other postretirement benefit plans - Ending balance		26	(32)	26	(32)
Unrealized Translation
Unrealized translation - Beginning balance				(2,297)	(1,864)
Other comprehensive income/(loss) before reclassifications				29	(254)
(Income)/loss reclassified from AOCI				0	1
Net current period other comprehensive income (loss)				29	(253)
Unrealized translation - Ending balance		(2,268)	(2,135)	(2,268)	(2,135)
Accumulated Foreign Currency Adjustment Attributable to Parent
Income Tax Effects Allocated Directly to Equity, Cumulative Effect of Change in Accounting Principle					(18)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Defined Benefit Pension Plans
Income Tax Effects Allocated Directly to Equity, Cumulative Effect of Change in Accounting Principle					(125)
Accumulated Defined Benefit Plans Adjustment Attributable to Parent | Other Postretirement Benefit Plans
Income Tax Effects Allocated Directly to Equity, Cumulative Effect of Change in Accounting Principle					(5)
Cash Flow Hedges and Other
Cash flow hedge and other - Beginning balance				3	(40)
Other comprehensive income/(loss) before reclassifications				(12)	15
(Income)/loss reclassified from AOCI				(8)	13
Net current period other comprehensive income (loss)				(20)	28
Cash flow hedge and other - Ending balance		$ (17)	$ (20)	$ (17)	(20)
Income Tax Effects Allocated Directly to Equity, Cumulative Effect of Change in Accounting Principle					$ (8)
[1]	Included in computation of net periodic benefit costs.

Leases (Narrative) (Details)

Leases (Narrative) (Details) $ in Millions	3 Months Ended	6 Months Ended
	Jun. 30, 2019USD ($)	Jun. 30, 2019USD ($)
Leases [Abstract]
Lessee Operating And Finance Leases Remaining Lease Terms	19 years
Operating And Finance Leases, Options To Extend Lease Terms	20 years
Operating And Finance Leases, Options To Terminate Lease Term	1 year
Operating Lease, Weighted Average Remaining Lease Term	4 years 4 months 24 days	4 years 4 months 24 days
Operating Lease, Weighted Average Discount Rate, Percent	5.20%	5.20%
Cash Paid for Amounts Included in the Measurement of Operating Lease Liabilities	$ 80	$ 80
Lessee, Operating Lease, Not Yet Commenced, Pending Right-of-Use Asset and Liability		$ 96
Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract	7 years	7 years

Lease, Cost (Details)

Lease, Cost (Details) - USD ($) $ in Millions		3 Months Ended	6 Months Ended
		Jun. 30, 2019	Jun. 30, 2019
Leases [Abstract]
Lease cost		$ 40	$ 79
Variable lease cost	[1]	35	72
Total lease cost		$ 75	$ 151
[1]	(a) Includes short-term leases, which are immaterial.

Leases Schedule of Lease Assets

Leases Schedule of Lease Assets and Liabilities (Details) $ in Millions	Jun. 30, 2019USD ($)
Leases [Abstract]
Lease assets	$ 416
Current lease liabilities	136
Noncurrent lease liabilities	291
Total lease liabilities	$ 427

Leases Lessee, Operating Lease,

Leases Lessee, Operating Lease, Liability, Maturity (Details) $ in Millions	Jun. 30, 2019USD ($)
Leases [Abstract]
2019	$ 79
2020	133
2021	90
2022	63
2023	44
Thereafter	74
Total lease payments	483
Less imputed interest	56
Present value of lease liabilities	$ 427

Leases Schedule of Future Minim

Leases Schedule of Future Minimum Rental Payments for Operating Leases (Details) $ in Millions	Dec. 31, 2018USD ($)
Leases [Abstract]
2019	$ 160
2020	123
2021	85
2022	57
2023	41
Thereafter	72
Future minimum obligations	$ 538

Objectives And Strategies For_2

Objectives And Strategies For Using Derivatives (Narratives) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss)
Gain (loss) on undesignated foreign exchange hedging instruments	$ (5)	$ (40)	$ (13)	$ (37)
Foreign currency exchange contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss)
Aggregate notional values of outstanding derivatives	1,700		1,700
Net Investment Hedging
Derivative Instruments, Gain (Loss)
Aggregate notional values of outstanding derivatives	1,500		1,500
Fair Value Hedging
Derivative Instruments, Gain (Loss)
Gain (loss) recognized in earnings as a result of hedge not qualifying as a fair value hedge				$ 0
Fair Value Hedging | Interest Rate Contract
Derivative Instruments, Gain (Loss)
Aggregate notional values of outstanding derivatives	300		300
Long-term Debt, Fair Value	308		$ 308
Cash Flow Hedging
Derivative Instruments, Gain (Loss)
Maximum Maturity Date			Mar. 31, 2021
Cash Flow Hedging | Foreign currency exchange contracts
Derivative Instruments, Gain (Loss)
Aggregate notional values of outstanding derivatives	657		$ 657
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2
Derivative Instruments, Gain (Loss)
Derivative Asset	31		31		$ 30
Derivative Liability	$ 34		$ 34		$ 18

Description Of Business Segme_3

Description Of Business Segments (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended		18 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019
Net Sales		$ 4,594	$ 4,604	$ 9,227	$ 9,335
Sales Revenue, Net, Percent Change		0.00%		(1.00%)
Operating Profit		$ 670	674	$ 1,325	921
Other (income) and expense, net		$ 5	10	$ 9	8
Operating Profit, Percent Change		(1.00%)		44.00%
2018 Global Restructuring Program | Before Tax
Restructuring Charges		$ 119	130	$ 271	707	$ 1,300
Personal Care
Net Sales		$ 2,286	2,257	$ 4,561	4,564
Sales Revenue, Net, Percent Change		1.00%		0.00%
Operating Profit		$ 485	461	$ 969	931
Operating Profit, Percent Change		5.00%		4.00%
Personal Care | 2018 Global Restructuring Program | Before Tax
Restructuring Charges		$ 66	87	$ 155	401
Consumer Tissue
Net Sales		$ 1,472	1,472	$ 2,998	3,051
Sales Revenue, Net, Percent Change		0.00%		(2.00%)
Operating Profit		$ 221	207	$ 462	456
Operating Profit, Percent Change		7.00%		1.00%
Consumer Tissue | 2018 Global Restructuring Program | Before Tax
Restructuring Charges		$ 36	18	$ 82	159
K-C Professional
Net Sales		$ 821	861	$ 1,638	1,693
Sales Revenue, Net, Percent Change		(5.00%)		(3.00%)
Operating Profit		$ 162	165	$ 312	323
Operating Profit, Percent Change		(2.00%)		(3.00%)
K-C Professional | 2018 Global Restructuring Program | Before Tax
Restructuring Charges		$ 15	6	$ 31	101
Corporate and Other
Net Sales		15	14	30	27
Operating Profit	[1]	(193)	(149)	(409)	(781)
Other (income) and expense, net
Other (income) and expense, net	[1]	$ 5	$ 10	$ 9	$ 8
Operating Profit, Percent Change		(50.00%)		13.00%
[1]	Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including charges related to the 2018 Global Restructuring Program. Restructuring charges related to the personal care, consumer tissue and K-C Professional business segments were $66 , $36 and $15 , respectively, for the three months ended June 30, 2019, $87 , $18 and $6 , respectively, for the three months ended June 30, 2018, $155 , $82 and $31 , respectively, for the six months ended June 30, 2019 and $401 , $159 and $101 , respectively, for the six months ended June 30, 2018.

Description Of Business Segme_4

Description Of Business Segments Sales of Principle Products (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Consolidated
Net Sales	$ 4,594	$ 4,604	$ 9,227	$ 9,335
Consumer Tissue Products
Consolidated
Net Sales	1,500	1,500	3,000	3,100
Baby and Child Care Products
Consolidated
Net Sales	1,600	1,600	3,100	3,200
Away-from-home Professional Products
Consolidated
Net Sales	800	900	1,600	1,700
All Other
Consolidated
Net Sales	$ 700	$ 600	$ 1,500	$ 1,300

Supplemental Balance Sheet Da_2

Supplemental Balance Sheet Data - Inventory (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Raw materials	$ 337	$ 362
Work in process	230	214
Finished goods	1,203	1,153
Supplies and other	267	275
Inventory, Gross	2,037	2,004
Excess of FIFO or weighted-average cost over LIFO cost	(181)	(191)
Total	1,856	1,813
LIFO
Raw materials	88	99
Work in process	134	120
Finished goods	485	461
Supplies and other	0	0
Inventory, Gross	707	680
Excess of FIFO or weighted-average cost over LIFO cost	(181)	(191)
Total	526	489
Non-LIFO
Raw materials	249	263
Work in process	96	94
Finished goods	718	692
Supplies and other	267	275
Inventory, Gross	1,330	1,324
Excess of FIFO or weighted-average cost over LIFO cost	0	0
Total	$ 1,330	$ 1,324

Supplemental Balance Sheet Da_3

Supplemental Balance Sheet Data - Property Plant and Equipment (Details) - USD ($) $ in Millions	Jun. 30, 2019	Dec. 31, 2018
Property, Plant and Equipment
Land	$ 169	$ 169
Buildings	2,831	2,787
Machinery and equipment	14,212	14,059
Construction in progress	760	699
Property, Plant and Equipment, Gross	17,972	17,714
Less accumulated depreciation	(10,765)	(10,555)
Total	$ 7,207	$ 7,159